Literature DB >> 16765378

Training of executive functions in Parkinson's disease.

Gebhard Sammer1, Iris Reuter, Katharina Hullmann, Manfred Kaps, Dieter Vaitl.   

Abstract

Cognitive disturbances are common in Parkinson's disease (PD). Examination of cognitive function often reveals deficits in executive functions, including maintenance and inhibition of attention, flexibility in thinking, and planning. The involvement of the dopaminergic system in cognitive executive functions has been suggested by numerous studies. The aim of the present study was to analyze the effect of cognitive training on cognitive performance of PD-patients (N=26). Half of the patients participated in a cognitive training regimen, while the other patients only received standard treatment. The outcome showed improved performance of the group with cognitive treatment in two executive tasks after the training period, while no improvement was seen in the standard-treatment group. The results indicate that specific training is required for improvement of executive functions, while general rehabilitation is not sufficient. Thus, PD-patients might benefit from a short-term cognitive executive function training program that is tailored to the individual patient's needs.

Entities:  

Mesh:

Year:  2006        PMID: 16765378     DOI: 10.1016/j.jns.2006.05.028

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  41 in total

1.  Feasibility of a cognitive strategy training intervention for people with Parkinson's disease.

Authors:  Erin R Foster; Daniel Spence; Joan Toglia
Journal:  Disabil Rehabil       Date:  2017-02-23       Impact factor: 3.033

Review 2.  [Cognitive functions of the prefrontal cortex: neuroscience and clinic].

Authors:  B Kopp; S Tabeling; C Moschner; K Wessel
Journal:  Nervenarzt       Date:  2008-02       Impact factor: 1.214

3.  Individual differences in executive functions are almost entirely genetic in origin.

Authors:  Naomi P Friedman; Akira Miyake; Susan E Young; John C DeFries; Robin P Corley; John K Hewitt
Journal:  J Exp Psychol Gen       Date:  2008-05

4.  Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study.

Authors:  Jürgen Keller; Martin Gorges; Hannah T Horn; Helena E A Aho-Özhan; Elmar H Pinkhardt; Ingo Uttner; Jan Kassubek; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

Review 5.  Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: emerging evidence.

Authors:  Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Mikhail N Koffarnus; Kirstin M Gatchalian
Journal:  Pharmacol Ther       Date:  2012-02-22       Impact factor: 12.310

6.  Randomized trial of cognitive speed of processing training in Parkinson disease.

Authors:  Jerri D Edwards; Robert A Hauser; Melissa L O'Connor; Elise G Valdés; Theresa A Zesiewicz; Ergun Y Uc
Journal:  Neurology       Date:  2013-09-06       Impact factor: 9.910

7.  Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study.

Authors:  Antonio Cerasa; Maria Cecilia Gioia; Maria Salsone; Giulia Donzuso; Carmelina Chiriaco; Sabrina Realmuto; Alessandra Nicoletti; Gabriele Bellavia; Aurelia Banco; Marco D'amelio; Mario Zappia; Aldo Quattrone
Journal:  Neurol Sci       Date:  2014-02-20       Impact factor: 3.307

8.  Treatment of psychosis and dementia in Parkinson's disease.

Authors:  Jennifer G Goldman; Samantha Holden
Journal:  Curr Treat Options Neurol       Date:  2014-03       Impact factor: 3.598

9.  A pilot study on the benefit of cognitive rehabilitation in Parkinson's disease.

Authors:  Natalia Adamski; Matthias Adler; Klaus Opwis; Iris-Katharina Penner
Journal:  Ther Adv Neurol Disord       Date:  2016-02-16       Impact factor: 6.570

10.  Sustained attention training reduces spatial bias in Parkinson's disease: a pilot case series.

Authors:  Joseph DeGutis; Mallory Grosso; Thomas VanVleet; Michael Esterman; Laura Pistorino; Alice Cronin-Golomb
Journal:  Neurocase       Date:  2015-09-11       Impact factor: 0.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.